Newsletter December 2022

Creating databases to help cure diseases worldwide

Jessica Kissinger is using her expertise in biology and big data to help other scientists >>Read More>>

Recently Funded Projects

Andrew Moorhead received a National Institutes of Health grant for the production and distribution of filiarial research reagents. He also received an award from the American Heartworm Society for a study to determine the optimum dose of doxcycline/ivermectin administration in treatment of Dirofilaria immitis.

Samarchith Kurup received a National Institutes of Health grant for the project Type-1 Interferons drive cell-autonomous immunity to malaria.

Christopher West, along with his colleagues at the State University of New York at Buffalo, received a National Institutes of Health grant to study protist oxygen sensing in human disease.

R. Drew Etheridge received a National Institutes of Health grant to study the mechanistic basis for phagotrophy in the protozoan Trypanosoma cruzi.

Chet Joyner, along with his colleagues at The Scripps Research Instituted, received funding from the Bill & Melinda Gates Foundation for phenotypic and transcriptional analysis of engineered antigen specific B cells and antibody secreting cells in nonhuman primates. He also received a National Institutes of Health with his colleagues at the University of Maryland to study host and parasite factors influencing P. vivax red blood cell invasion and asexual development. Joyner and his colleagues at MRIGlobal received a U.S. Department of Defense grant to evaluate the impact of freeze-thaw cycle on the detection of Plasmodium falciparum using Tropical Fever tests on Gx and Omni instruments. With colleagues at the University of Arizona and Emory University, Joyner received funding to study the homing properties of the optimal “synthetic plasma cell” product in NHPs.

Ynes Ortega received a grant from Pure Bioscience, Inc. to study the use of silver based disinfectant against parasites.

M. Belen Cassera, with her colleagues at the University of Illinois – Chicago, received a National Institutes of Health grant to optimize antimalarials targeting multiple life stages of the parasite.